Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.
The New England journal of medicine.
Times cited: 2
- Identification of a novel activating mutation (Y842C) within the activation loop of FLT3 in patients with acute myeloid leukemia (AML). Blood. 2005 Academic Article GET IT
Signal transduction pathways induced by heregulin in MDA-MB-453 breast cancer cells.
Times cited: 60